Advertisement

Cardiovascular Drugs and Therapy

, Volume 4, Issue 3, pp 751–754 | Cite as

The effect of captopril on peripheral hemodynamics in patients with esential hypertension: Comparison between oral and sublingual administration

  • Carlo Longhini
  • Lucia Ansani
  • GianFranca Musacci
  • Donato Mele
  • Marco Vaccari
  • Enrico Baracca
  • Paolo Sgobino
Hypertension

Summary

A comparative study of the effects of oral and sublingual captopril on the hemodynamics of the peripheral musculocutaneous vasculature was carried out on ten patients with essential hypertension. Both routes of administration of captopril lead to lower blood pressure and decreased regional resistance, and to an increased arterial blood flow at rest. The first measurable effect and the peak effect on blood pressure and peripheral hemodynamics appear slightly earlier with sublingual administration. The data provided in this study support the usefulness of the sublingual route in clinical situations in which oral administration of captopril is not feasible.

Key Words

captopril peripheral hemodynamics essential hypertension strain gauge plethysmography sublingual administration 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Unger T, Ganten D, Lang RE. Converting enzyme inhibitors: Antihypertensive drugs with unexpected mechanisms.Trends Pharmacol Sci 1983;4:514–519.Google Scholar
  2. 2.
    Riley LJ, Vlasses PH, Pharm D, et al. Clinical pharmacology and therapeutic applications of the new oral converting enzyme inhibitor, enalapril.Am Heart J 1985;109:1085–1089.PubMedGoogle Scholar
  3. 3.
    Swartz SL, Williams GH. Angiotensin-converting inhibition and prostaglandins.Am J Cardiol 1982;49:1405–1409.PubMedGoogle Scholar
  4. 4.
    Salvetti A, Pedrinelli R, Arzilli F. Il ruolo del sistema renina-angiotensina-aldosterone nella regolazione della pressione arteriosa.Cardiologia 1985;30(Suppl 3):3–9.PubMedGoogle Scholar
  5. 5.
    Ribeiro AB, Kohlmann O Jr, Saragoca MAS, et al. The renin-angiotensin system in the control of systemic arterial pressure.Drugs 1985;30(Suppl 1):6–12.Google Scholar
  6. 6.
    Zimmermann BG, Sybertz EJ, Wong PC. Interaction between sympathetic and renin-angiotensin system.J Hypertens 1984;2:S81-S87.Google Scholar
  7. 7.
    Antonaccio MJ, Kerwin L. Pre- and postjunctional inhibition of vascular sympathetic function by captopril in SHR.Hypertension 1981;3(Suppl 1):54–62.Google Scholar
  8. 8.
    Degli Esposti E, Chiarini C, Mari A, et al. The effects of captopril on blood pressure in essential hypertensive patients with low or normal plasma renin activity. Interference with the autonomic nervous system.Clin Exp Hypertens 1981;3:439–454.PubMedGoogle Scholar
  9. 9.
    De Jonge A, Wilffert B, Kalkman HO, et al. Captopril impairs the vascular smooth muscle contraction mediated by post-synaptic alpha2-adrenoceptors in the pithed rat.Eur J Pharmacol 1981;74:385–386.PubMedGoogle Scholar
  10. 10.
    Morganti A, Grassi G, Sala C, et al. Acute and chronic converting enzyme inhibition reduces the vasomotor response to reflex sympathetic activation in man.J Hypertens 1985;3(Suppl 3):S259-S262.Google Scholar
  11. 11.
    Brown JJ, Casals-Stenzel J, Cumming AMM, et al. Angiotensin II, aldosterone and arterial pressure: A quantitative approach.Hypertension 1979;1:159–179.PubMedGoogle Scholar
  12. 12.
    Sanchez RA, Marco E, Gilbert HB, et al. Natriuretic effect and changes in renal haemodynamics induced by enalapril in essential hypertension.Drugs 1985;30(Suppl 1):49–58.PubMedGoogle Scholar
  13. 13.
    Jenkins AC, Dreslinski GR, Tadros SS, et al. Captopril in hypertension: Seven years later.J Cardiovasc Pharmacol 1985;7(Suppl 1):S96-S101.Google Scholar
  14. 14.
    Stumpe KO, Kolloch R, Overlack A. Captopril and enalapril: Evaluation of therapeutic efficacy and safety.Pract Cardiol 1984;10:111–124.Google Scholar
  15. 15.
    Fitzpatrick MA, Julius S. Haemodynamic effects of angiotensin-converting enzyme inhibitors in essential hypertension: A review.J Cardiovasc Pharmacol 1985;7(Suppl 1):S35-S39.Google Scholar
  16. 16.
    Ohman KP, Kagedal B, Larsson R, et al. Pharmacokinetics of captopril and its effects on blood pressure during acute and chronic administration and in relation to food intake.J Cardiovasc Pharmacol 1985;7(Suppl 1):S20-S24Google Scholar
  17. 17.
    Tschollar W, Belz GG. Sublingual captopril in hypertensive crisis.Lancet 1985;2:34–35.Google Scholar
  18. 18.
    Opie LH, Jennings A. Sublingual captopril versus nifedipine in hypertensive crisis.Lancet 1985;2:555.Google Scholar
  19. 19.
    Hauger-Klevene JH. Captopril in hypertensive crisis.Lancet 1985;2:732–733.Google Scholar
  20. 20.
    Perroni GB, Longo FN, Girasella R, et al. Effetti del captopril somministrato per via sublinguale in corso di crisi ipertensive (primi risultati).Rivista Ospedaliera (Messina) 1984;I(8):233–237.Google Scholar
  21. 21.
    Hauger-Klevene JH. Comparison of sublingual captopril and nifedipine.Lancet 1986;1:219.PubMedGoogle Scholar
  22. 22.
    Hauger-Klevene JH. Treatment of clonidine rebound syndrome with sublingual captopril.N Engl J Med 1986;314:181–182.Google Scholar
  23. 23.
    Perroni GB, Longo FN, Trovato G, et al. Effetti del captopril sublinguale sulla pressione arteriosa e venosa nell'uomo.Eur Rev Med Pharmacol Sci 1986;8:203–212.Google Scholar
  24. 24.
    Marigliano V, Santilli D, Fiorani M, et al. Hypertensive emergencies in old age: effects of angiotensin converting enzyme inhibition.J Hypertens 1988;6(Suppl 1):S91-S93.Google Scholar
  25. 25.
    Polonia JJ, Monteiro A, Esteves A, et al. Influence of sublingual captopril on plasma catecholamine levels during hypertensive emergencies and cold immersion.Am J Med 1988;84(Suppl 3A):148–151.PubMedGoogle Scholar
  26. 26.
    Dessi'-Fulgheri P, Bandiera F, Rubattu S, et al. Comparison of sublingual and oral captopril in hypertension.Hypertension Clin Exper—Theory Pract 1987;A9(2,3):593–597.Google Scholar
  27. 27.
    Tschollar W, Belz GG, Essig J, et al. Fast and safe blood pressure reduction from sublingual captopril.J Am Coll Cardiol 1987;9(2):226.Google Scholar
  28. 28.
    Clarke RSJ, Helton RF: Venous collection in forearm and hand measured by strain gauge and volume plethysmography.Clin Sci 1957;16:103–109.PubMedGoogle Scholar
  29. 29.
    Longhini C, Musacci GF, Ansani L, et al. Peripheral hemodynamic response to angiotensin converting enzyme inhibitor single administration in hypertensive patients.Curr Ther Res 1984;35:707–713.Google Scholar

Copyright information

© Kluwer Academic Publishers 1990

Authors and Affiliations

  • Carlo Longhini
    • 1
  • Lucia Ansani
    • 1
  • GianFranca Musacci
    • 1
  • Donato Mele
    • 1
  • Marco Vaccari
    • 1
  • Enrico Baracca
    • 1
  • Paolo Sgobino
    • 1
  1. 1.Istituto di Clinica MedicaUniversita' di FerraraFerraraItaly

Personalised recommendations